Abnormal Changes of Monocyte Subsets in Patients With Sjogren's Syndrome

BackgroundRecent studies have proven the existence of distinct monocyte subsets, which play a significant role in the development of some rheumatic diseases such as systemic lupus erythematosus (SLE). This study was performed to define the changes of monocyte subsets in patients with Sjogren's Syndrome (SjS). MethodsSingle cell RNA-sequencing (scRNA-seq) data of monocytes from SjS patients and controls were analyzed. The transcriptomic changes in monocyte subsets between SjS and controls were identified and potential key functional pathways involved in SjS development were also explored. ResultsA total of 11 monocyte subsets were identified in the scRNA-seq analyses of monocytes. A new monocyte subset characterized by higher expression of VNN2 (GPI-80) and S100A12 (Monocyte cluster 3) was identified, and it was increased in SjS patients. Compared with controls, almost all monocyte subsets from SjS patients had increased expression of TNFSF10 (TRAIL). Moreover, interferon (IFN)-related and neutrophil activation-associated pathways were main up-regulated pathways in the monocytes of SjS patients. ConclusionThis study uncovered the abnormal changes in monocyte subsets and their transcriptomic changes in SjS patients, and identified TNFSF10 (high/+) monocytes as a potential key player in SjS pathogenesis and a promising target for SjS treatment.

Automated summary

This study analyzed the single cell RNA sequencing data of monocytes from Sjögren's Syndrome (SjS) patients and identified abnormal changes in monocyte subsets. TNFSF10 monocytes were identified as potential key players in SjS pathogenesis and a promising target for SjS treatment.